Bioavailability, Drug Delivery Systems and Regulation

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bioavailability

Drug Delivery Systems

Regulation

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

XTalks

AUGUST 30, 2022

A major obstacle for CNS drug developers is the inability to target therapies to the CNS broadly (for instance, a therapy that is orally bioavailable as a pill and has difficulty crossing the blood-brain barrier) and certain CNS regions more specifically. The patients are waiting! Modern-Day Applications of Direct CNS Administration.

Trials

Trials Drug Delivery Drugs Gene

Mitigating the risks of cross-contamination during Oral Solid Dose (OSD) manufacturing

Pharmaceutical Technology

FEBRUARY 3, 2023

In 2021, 72% of newly approved drugs were small molecules, and almost 50% of new drugs approved were OSD. While the industry is seeing advances in alternative drug delivery systems, oral solid doses, such as pills, capsules and soft gels, remain at the forefront of the industry.

Contamination

Contamination Manufacturing Containment Production

Clinical Research Informer

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

Mitigating the risks of cross-contamination during Oral Solid Dose (OSD) manufacturing

Stay Connected